Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant

NCT05611307 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT05611307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05611307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant
Lead sponsor
Indiana University
Phase
Observational
Overall status
Recruiting
Start date
October 11, 2022
Completion date
August 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascvd, bone marrow transplant complications, cisplatin adverse reaction, coronary artery disease, hypogonadism, male, lipid disorder, survivorship, testicular cancer